Circumvent Pharmaceuticals Inc.

From the company

Circumvent Pharmaceuticals is a company formed with the mission of developing precision medicines for neurodegenerative disease, starting with Batten Disease. It has built a team of scientists and clinicians focused on diseases with predictive animal models and a clear clinical development path. Its research has uncovered insights into brain-cell dysfunction, including synaptic function, protein localization, lysosomal function, autophagy, the palmitoylome, and the synaptome. Its current drug programs target CLN1 Batten Disease and other rare neurologica